In-vitro activity of new sulphanilil fluoroquinolones against Staphylococcus aureus
- PMID: 7814287
- DOI: 10.1093/jac/34.2.261
In-vitro activity of new sulphanilil fluoroquinolones against Staphylococcus aureus
Abstract
Two new quinolones, NSFQ-104 and NSFQ-105, derivatives of ciprofloxacin and norfloxacin with a 4-(4-aminophenylsulphonyl)-1-piperazinyl at position 7 showed better in-vitro activity against strains of methicillin-susceptible and methicillin-resistant Staphylococcus aureus than ciprofloxacin or norfloxacin. Their in-vitro activity was enhanced at pH 5.5.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
